Tempest Therapeutics, Inc.

Biotech Brisbane, CA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Brisbane, CA
Street
2000 Sierra Point Parkway
Zip
94005

Offering

Total offering
$2M
Amount sold
$2M
First sale
Mar 20, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
3

How this filing compares

Ranked #27 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.7× the median.

Other California filings this week: 3700 Ascent LLC, 3MR JSW Mission Investors, LP, Beach Point SCF IX Loan LP, Beach Point SCF V LP, Belveron Flagship Fund VIII Investor LP

Leadership

Matthew Angel — Executive Officer (also: Director)

Nicholas Maestas — Executive Officer

Michael Raab — Director

Christine Pellizzari — Director

Ronit Simantov — Director

Stephen Brady — Director

Filing details

Tempest Therapeutics, Inc. filed a Form D with the SEC on April 3, 2026.

Other newest Biotech companies

Other newest companies in California